Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122124612 | 12212461 | 2 | F | 20160829 | 20160326 | 20160901 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-021162 | BRISTOL MYERS SQUIBB | 70.00 | YR | M | Y | 0.00000 | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122124612 | 12212461 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | U | 202155 | ||||||||||
| 122124612 | 12212461 | 2 | SS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122124612 | 12212461 | 1 | Thrombosis prophylaxis |
| 122124612 | 12212461 | 2 | Cerebrovascular accident |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122124612 | 12212461 | OT |
| 122124612 | 12212461 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122124612 | 12212461 | Cerebrovascular accident | |
| 122124612 | 12212461 | Contraindicated product administered |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |